Patient Square Capital LP

Q4 2024 13F Holdings

  • Location
    menlo park, CA
  • Num holdings

    20

  • Value ($000)

    $267,375

  • Date Filed
    02/14/2025
  • Form type
    13F-HR
  • CIK
    0001819257
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2024 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
---

ROIVANT SCIENCES LTD

SHS
G76279101
$147.64M
55 %

12,480,000

LQDA
LQDA

LIQUIDIA CORPORATION

COM NEW
53635D202
$21.88M
8 %

1,860,371

INSM
INSM

INSMED INC

COM PAR $.01
457669307
$21.21M
8 %

307,167

CGEM
CGEM

CULLINAN THERAPEUTICS INC

COM
230031106
$10.70M
4 %

878,897

EYPT
EYPT

EYEPOINT PHARMACEUTICALS

COM NEW
30233G209
$10.51M
4 %

1,410,331

NRIX
NRIX

NURIX THERAPEUTICS, INC.

COM
67080M103
$8.41M
3 %

446,296

ITCI
ITCI

INTRA-CELLULAR THERAPIES INC.

COM
46116X101
$6.01M
2 %

71,990

ELVN
ELVN

ENLIVEN THERAPEUTICS INC

COM
29337E102
$5.04M
2 %

224,038

GON
GON

GERON CORPORATION

COM
374163103
$4.68M
2 %

1,321,268

OCUL
OCUL

OCULAR THERAPEUTIX, INC.

COM
67576A100
$4.02M
2 %

470,919

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 20